Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 42.49 |
| Open | 42.80 |
| Bid | 41.50 x 100 |
| Ask | 43.75 x 200 |
| Day's range | 42.80 - 42.80 |
| 52-week range | 27.99 - 50.99 |
| Volume | |
| Avg. volume | 374,388 |
| Market cap | 3.23B |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- GuruFocus.com
Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...
Xenon Pharmaceuticals Inc (NASDAQ:XENE), a clinical-stage biopharmaceutical company, focuses on developing therapeutics to improve the lives of patients with neurological disorders.
- Insider Monkey
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript February 29, 2024 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.64, expectations were $-0.76. Xenon Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
© 2024 Yahoo. All rights reserved.